FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Aspirin and Omeprazole (Yosprala) Tablets
Status: Discontinuation
»Therapeutic Categories: Cardiovascular

Expand all

Aralez Pharmaceuticals Trading (New 06/13/2018)

Company Contact Information:
609-917-9295

Presentation Posting Date Related Information
81 mg/40 mg, 30 ct bottle (NDC 70347-081-30) and 90 ct bottle (NDC 70347-081-90) 06/13/2018 Aralez has made a business decision to permanently discontinue Yosprala tablets.
325 mg/40 mg, 30 ct bottle (NDC 70347-325-30) and 90 ct bottle (NDC 70347-325-90) 06/13/2018 Aralez has made a business decision to permanently discontinue Yosprala tablets.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English